secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001140361-25-022762
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys appoints Kelley Nicholas as CCO; grants 100,000-share inducement option
-------------------------------------------------------------------------------

- Appointed Kelley Nicholas as Chief Commercial Officer effective June 17, 2025; she will lead U.S. commercialization and global partnerships.
- Nicholas brings over 25 years experience from NeuroPace, Hologic, Medtronic, Baxter, Intuitive Surgical.
- As inducement, Femasys granted option to purchase 100,000 shares vesting over 4 years (25% after 1 year, then 25% annually).
- Focus on expanding U.S. infertility market for FemaSeed and building international partnerships across full portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125022762/0001140361-25-022762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125022762/ef20050687_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-022762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer